At Pinnacle Health our commitment to health equity goes beyond words — it is backed by evidence. Our medical director, Dr Jo Scott-Jones, recently joined partners in academia to examine how primary care can close gaps and improve outcomes for people with type 2 diabetes.
Supported by the New Zealand Health Research Council, this research confirms what we see in practice:
This work shows the value of strong partnerships between healthcare providers, researchers and universities, and Pinnacle is proud to be actively engaging in such partnerships.
The research is published across several recent studies with the University of Waikato and academic partners.
We remain steadfast to our role in driving equitable and evidence-based healthcare, ensuring whānau across Aotearoa can access the right care at the right time wherever they are.
He waka eke noa — we’re all in this together.
Mauri ora.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreFrom 1 December 2025, Pharmac will remove Special Authority renewal requirements for several treatments, including insulin pump consumables, continuous glucose monitors, LAMA/LABA inhalers, epoetin alfa, budesonide capsules, and febuxostat.
Read moreFunding for patients who require a follow-up appointment following HbA1c retest by Awanui Labs.
This funding ends on 28 February 2026
A guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.